Biochemical and immuno- and lectin-histochemical studies of solubility and retention of bone matrix proteins during EDTA demineralization.
The present study utilized biochemical and immuno- and lectin-histochemical methods to demonstrate solubility and retention of mineral-binding non-collagenous proteins in rat midshaft subperiosteal bone during EDTA demineralization. A monoclonal antibody (9-A-2) specific for chondroitin 4-sulphate and dermatan sulphate and wheat germ agglutinin (WGA) specific for N-acetyl-D-glucosamine, N-acetylneuraminic acid, and N-acetyl-D-galactosamine were used. Bone proteins were extracted from fresh unfixed or aldehyde-fixed specimens with a three step extraction procedure, 4 M guanidine HCl (GdnCl), aqueous EDTA without GdnCl, followed by GdnCl. For comparison with the second extraction step, ethanolic trimethylammonium EDTA (ethanolic EDTA) was substituted for aqueous EDTA. Based on protein staining and Western blot analysis of SDS-polyacrylamide gel electrophoresis of each extract using 9-A-2 and WGA, retention of mineral-binding proteins extractable from fresh specimens with aqueous EDTA was greatly increased in tissue when ethanolic EDTA was used. Their retention was even greater with prior aldehyde fixation. Maximum retention with no detectable solubility of 9-A-2 and WGA reactive proteins was obtained after ethanolic EDTA extraction of aldehyde-fixed specimens, which concomitantly provided the strongest immuno- and lectin staining. These results indicate that this combined method dramatically improves retention of PGs and glycoproteins during demineralization of bone tissues and provides the best method for localizing these glycoconjugates.
Takagi
M
M
Department of Anatomy, Nihon University School of Dentistry, Tokyo, Japan.
Maeno
M
M
Takahashi
Y
Y
Otsuka
K
K
D000116:Acetylgalactosamine / Q000032:analysis; D000117:Acetylglucosamine / Q000032:analysis; D000818:Animals; D015153:Blotting, Western; D001857:Bone Matrix / Q000737:chemistry* / Q000187:drug effects; D001842:Bone and Bones / Q000737:chemistry* / Q000187:drug effects; D002809:Chondroitin Sulfates / Q000032:analysis; D003871:Dermatan Sulfate / Q000032:analysis; D004492:Edetic Acid / Q000494:pharmacology; D005269:Femur / Q000033:anatomy & histology / Q000737:chemistry; D005404:Fixatives; D006651:Histocytochemistry; D006811:Humerus / Q000033:anatomy & histology / Q000737:chemistry; D007150:Immunohistochemistry; D010521:Periosteum / Q000033:anatomy & histology / Q000737:chemistry; D011509:Proteoglycans / Q000032:analysis*; D051381:Rats; D011919:Rats, Inbred Strains; D012794:Sialic Acids / Q000032:analysis; D012995:Solubility; D016707:Tissue Fixation; D014909:Wheat Germ Agglutinins
D005404:Fixatives; D011509:Proteoglycans; D012794:Sialic Acids; D014909:Wheat Germ Agglutinins; D003871:Dermatan Sulfate; D002809:Chondroitin Sulfates; D004492:Edetic Acid; D000116:Acetylgalactosamine; D000117:Acetylglucosamine